What is the most unusual thing you have done as a scientist?Īll research is somehow unusual. I will love to ask her how she came up with the endosymbiotic theory that explains the origin of eukaryotic cells. The least I like is the amount of effort to extract enough DNA from medicines, not an easy task! If you could have tea with another scientist (alive or dead), who would it be? What would you talk about? I really like the applicable side of my current research. What do you like best about your job? What do you like the least? In the area of drug quality and pharmaceutical forensics, a major challenge is to unambiguously identify eDNA sequences in falsified drugs that were actually added to them during the manufacturing process and that correspond to biological species that can be mapped to narrow geographic origins. In the field of environmental genomics, I think one of the biggest challenges is the lack of complete databases, e.g., for species, that equally represent biological groups. What are the major challenges in your field? In addition, falsified antimicrobials often contain suboptimal concentrations of the active pharmaceutical ingredient, which promotes the emergence of antibiotic resistance. Falsified antimicrobials increase mortality and morbidity due to treatment failures.
Reportedly, about 10% of medical products worldwide are falsified, of which falsified antimicrobials (e.g., antibiotics and antimalarials) account for about 40%. Why is your research important? How is it relevant to people's lives? My goal is to determine if the biological profiles of these antimicrobials can provide information about their geographic origin (e.g., by mapping biological species with narrow geographic distributions) and thereby inform local authorities about their production sites. In my postdoctoral research project, I am applying next-generation eDNA sequencing to characterize the microbial and eukaryotic communities (also known as Pharmabiome ) associated to falsified antimicrobials. Rob Ogden's group, where she is performing targeted next-generation sequencing of microbial and eukaryotic communities associated with falsified antimicrobials to determine if the biological profiles of these antimicrobials can be used to determine their origin. She is currently a postdoctoral researcher in Forensic Environmental Genomics in Prof. She recently completed her PhD at ETH -Zurich, where she applied metabarcoding and metagenomics to study the diversity and functionality of microbial communities in permafrost soils. She has experience in monitoring field and in vitro experiments, molecular biology, amplicon sequencing and metagenomics, biochemical characterization of soil and water samples, project management, and statistical data analysis. She completed internships in developmental biology, developmental neurobiology, and cancer research. Today she splits her time between speaking about her climbing experiences all around the world, chasing new missions with her parter “Topo” and guiding big mountains.Carla is a trained environmental microbiologist with a background in biology and genetics.
In 2008 she did a biking trip from Ecuador to Argentina and had the opportunity to understand and learn more about her home: the Andes. She was also the first woman from the Americas to summit K2 without supplemental oxygen in 2019, and was the first woman to summit Everest and K2 in the same year. She was the sixth women in history to accomplish this feat and the first Latin American woman to do so. Carla has trained with and is pursuing UIAGM/IFMGA certification with the ASEGUIM (the Ecuadorian mountain guides association).Ĭarla has made multiple successful summits of Everest, including an ascent without the use of supplemental oxygen in 2016.
#Carla perez full
In 2007 she decided to become a full time climber, which also put her the path of becoming a mountain guide.
0 kommentar(er)
